---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-119894"
form_type: "8-K"
ticker: "APUS"
cik: "0001894525"
company_name: "Apimeds Pharmaceuticals US, Inc."
filed_at: "2025-12-10T23:59:59+00:00"
generated_at: "2026-05-16T13:40:57.946610+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Two directors resign from Apimeds Pharmaceuticals board effective December 5, 2025

## Summary
- Dr. Vin Menon and Amir A. Dossal resigned from the Board of Directors on December 5, 2025.
- Resignations were not due to any disagreement with the company's operations, policies, or practices.
- Dr. Vin Menon remains CEO of the company; no replacements for the vacant board seats announced.

## SEC filing metadata
- accession: 0001213900-25-119894
- form_type: 8-K
- ticker: APUS
- cik: 0001894525
- company_name: Apimeds Pharmaceuticals US, Inc.
- filed_at: 2025-12-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1894525/000121390025119894/0001213900-25-119894-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1894525/000121390025119894/ea0268648-8k_apimeds.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-119894
- JSON: https://secwatch.observer/filing/0001213900-25-119894.json
- Plain text: https://secwatch.observer/filing/0001213900-25-119894.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.